EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Viral codon optimization on SARS‐CoV‐2 Spike boosts immunity in the development of COVID‐19 mRNA vaccines

Chih-Jen Lai, Dokyun Kim, Seokmin Kang, Kun Li iD, Inho Cha, Akimi Sasaki, Jose Porras, Tian Xia, Jae U Jung

Journal of Medical Virology · 2023

DOI: 10.1002/jmv.29183 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Chih-Jen Lai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Biology and Infection Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Codon, COVID-19, COVID-19 Vaccines, Spike Glycoprotein, Coronavirus. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Korea Research Institute of Bioscience and Biotechnology, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Life‐long persistent herpesviruses carry “trans‐inducers” to overcome the unusual codon usage of their glycoproteins for efficient expression. Strikingly, this “trans‐inducibility” can be achieved by simply changing the codon‐usage of acute virus glycoproteins to that of persistent herpesvirus glycoproteins with herpesviral trans‐inducer. Here, we apply the “persistent viral codon‐usage‐trans‐inducer” principle to SARS‐CoV‐2 Spike mRNA vaccine platform, in which the codon‐usage of Spike is changed to that of Herpes Simplex Virus‐1 (HSV‐1) glycoprotein B (gB) with its “trans‐inducer” ICP27. The HSVgB‐ICP27‐codon‐optimized Spike mRNA vaccine induced markedly high antigen expression and stability, total IgG, neutralizing antibody, and T cell response, ultimately enhancing protection against lethal SARS‐CoV‐2 challenge. Moreover, the HSVgB‐ codon‐optimized Delta (B.1.617.2) strain Spike mRNA vaccine provided significant enhancements in antigen expression and long‐term protection against SARS‐CoV‐2 challenge. Thus, we report a novel persistent viral codon‐usage‐trans‐inducer mRNA vaccine platform for enhanced antigen expression and long‐term protection against lethal viral infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CodonCOVID-19COVID-19 VaccinesSpike Glycoprotein, CoronavirusHumansAntibodies, NeutralizingAntibodies, ViralGlycoproteinsSARS-CoV-2Viral Vaccines

Stichwörter der Autor:innen

Delta strainHerpes Simplex Virus-1 (HSV-1) glycoprotein B (gB)ICP27SARS-CoV-2mRNA vaccine

Substanzen

Antibodies, NeutralizingAntibodies, ViralCodonCOVID-19 VaccinesGlycoproteinsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Viral Vaccines

Autor:innen und Institutionen

  • Department of Cancer Biology and Infection Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Global Center for Pathogen Research and Human Health, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Florida Research and Innovation Center, Cleveland Clinic, Port St. Lucie, Florida, USA.
  • Department of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.

ORCID-Profile: Kun Li

Förderung

  • National Research Foundation of Korea
  • Korea Research Institute of Bioscience and Biotechnology
  • National Institutes of Health

Zitieren

APA

Lai, C. J., Kim, D., Kang, S., Li, K., Cha, I., Sasaki, A., Porras, J., Xia, T., & Jung, J. U. (2023). Viral codon optimization on SARS‐CoV‐2 Spike boosts immunity in the development of COVID‐19 mRNA vaccines. Journal of Medical Virology. https://doi.org/10.1002/jmv.29183

Vancouver

Lai CJ, Kim D, Kang S, Li K, Cha I, Sasaki A, et al. Viral codon optimization on SARS‐CoV‐2 Spike boosts immunity in the development of COVID‐19 mRNA vaccines. Journal of Medical Virology. 2023. doi:10.1002/jmv.29183

BibTeX
@article{Lai2023,
  author = {Lai, Chih-Jen and Kim, Dokyun and Kang, Seokmin and Li, Kun and Cha, Inho and Sasaki, Akimi and Porras, Jose and Xia, Tian and Jung, Jae U},
  title = {Viral codon optimization on SARS‐CoV‐2 Spike boosts immunity in the development of COVID‐19 mRNA vaccines},
  journal = {Journal of Medical Virology},
  year = {2023},
  doi = {10.1002/jmv.29183}
}
Kostenlos starten →